Opus Genetics, Inc. · NASDAQ:IRD
Caligan Partners LP reported a 6.20% stake in Opus Genetics, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Caligan Partners LP reported a 6.20% stake in Opus Genetics, Inc., 5,960,972 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 5,960,972
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Caligan Partners LP | 6.20% | 5,960,972 |
| JOHNSON DAVID EDWARD | 6.20% | 5,960,972 |
Source
Download original · View original at SEC
Related
- Opus Genetics, Inc.
- Caligan Partners LP
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G · Boxer Capital Management, LLC · Nov 16, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Nov 16, 2026
- Schedule 13G · Cormorant Asset Management, LP · Nov 16, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 12, 2026